| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE | /s/ Thomas Rowland, by attorney-in-fact Meredith W. Cook | 13 Feb 2026 | 0001507496 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIP | Common Stock | Tax liability | $134,352 | -1,762 | -4.3% | $76.25 | 39,160 | 11 Feb 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,788 performance stock units, the grant of which was previously reported. |
| F2 | Includes 128 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c). |